Clinical Trial Outcomes — Anonymized (2024)
Published Mar 2, 2026·1 views·0 inquiries
Anonymized clinical trial outcome data covering 340 Phase II and Phase III trials completed in 2024. Includes efficacy endpoints, adverse event frequencies, demographic breakdowns, and protocol metadata. HIPAA-safe with k-anonymity (k=5) guarantees. Useful for pharmaceutical research, biostatistics, and health economics.
healthcareclinical-trialspharmahealthcareanonymizedhipaabiostatistics
Schema Information
| Column | Type |
|---|---|
| trial_id | string |
| phase | string |
| therapeutic_area | string |
| primary_endpoint | string |
| efficacy_result | float |
| adverse_events | json |
| demographics | json |
| protocol_id | string |
Compliance
Status: not checked
$2,500.00
Buy Now — $2,500.00
Sign up to purchase this dataset
Trust Metrics
Privacy Score9.8/10
Quality Score0/100
Trust LevelNew
Verificationunverified
Publisher
Ask a Question
Get an instant AI-powered answer, or your question will be forwarded to the seller.
You'll need to sign in to submit your question.
Non-Custodial
Data never touches ai.market. Transactions are peer-to-peer.